Chemist

Ipca has been continuously evolving as an integrated pharmaceutical company over 65 years. Ipca has an annual turnover in excess of Rs.3,120 Crores with over 350 formulations and 80 APIs for various therapeutic segments. We are committed to Research & Development and expanding our R&D capabilities to build a strong future. cGMP (current Good Manufacturing Practices) & Safety is a way of life. We are committed to further enhance cGMP and safety journey on continuous basis to deliver safe and quality products for mankind and to build a safe workplace for our employees. Our manufacturing facilities of bulk drugs at Ratlam have earned accreditation and approvals from the worlds most vigilant regulatory bodies.

We, Gufic Lifesciences Private Limited is coming with manufacturing facilities of PIC's, MHRA, USFDA requirement for formulation of Lyophilization injectables at Navsari (Gujarat) for which we are looking for competent candidates.

In view of existing operational requirement and future expansions, it is proposed to recruit quality educational freshers from different locations across India, as a part of this we have planned Walk-in Interviews at HETERO(Corporate), Sanathnagar on 25th Nov, 2016 and the details are as follows: Requirement Details:

Post : Junior Officer/ Junior Research Associate/chemist - Formulations

The grape growers of India were among the first to form a cohesive non-political, non-racial and non-religious group for sharing the knowledge and for garnering technical and administrative support for the grape industry in all facets of grape production, processing and marketing. Owing to several problems faced by grape growers with respect to grape production and to get their problems solved, the group approached the Indian Council of Agricultural Research to establish a dedicated research unit for working on grapes. Thus after due deliberation on the research needs of grape growers and the grape industry and also to address the future challenges and opportunities, the Indian Council of Agricultural Research approved the establishment of National Research Centre for Grapes vide sanction letter No.1 (2)/92-PI&M (Part-III) dated 16 September, 1993.

SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation) and Human health (API). Leading API manufacturing Company in India.

[adsense:336x280:8701650588]

BEHR is a dynamic company that actively embraces quality and innovation to bring our industry and our customers the very best products and services. Our bold entrepreneurial spirit and our commitment to integrity and to doing the right thing has been the cornerstone of our success since 1947.

Post : Senior R & D Chemist

INTERNATIONAL TRAINING PROGRAMME

ON

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into tangible products to improve human health.
THSTI has set up niche centres for research in areas relevant to planned translational work. They are: Vaccine and Infectious Disease Research Centre (VIDRC), Paediatric Biology Centre (PBC), Centre for Bio-design & Diagnostics (CBD), Drug Discovery Research Centre (DDRC), Centre for Human Microbial Ecology (CHME) and Policy Centre for Biomedical Research (PCBR). Clinical Development Services Agency (CDSA) and National Bio-design Alliance (NBA) are THSTI’s extramural centres.

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur. The vision of first Prime Minister of India, Late Pt. Jawahar Lal Nehru regarding Indian Drug Industry was that “the drug industry must be in the public sector….. I think an industry of the nature of the drug industry should not be in the private sector anyhow. There are for too much exploitation of the public in this industry”. With the vision of the then Prime Minister of India, IDPL was incorporated in April, 1961 (Company Registration No. 3418 of 1961-1962 with Registrar of Companies, Delhi and having its Registered and Corporate Office at Gurgaon) with main objectives of creating self-sufficiency in respect of essential life saving medicines, to free the country from dependence on imports and to provide medicines to the millions at affordable prices and not to make millions from the medicines. IDPL was basically conceived and established as a part of Healthcare Infrastructure and has played a pioneering infra-structural role in the growth of Indian Drug Industry base.

IDPL is conducting Walk - in - Interview for the following posts purely on Contract Basis for Gurgaon Plant, Head Office/Corporate Office  and Rishikesh Plant as per details: